CCL2 and cancer: Focusing on CCL2 genetic regulation as a PARP1 target, we show that PARP1 interacts with the NFκB P65 subunit, thereby maintaining transcription of CCL2. CCL2, in turn, can positively modulate PARP1 activity in cancer cells (Figure 6D).